BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
See today's BioWorld
Home
» Other news to note for Feb. 24, 2021
To read the full article
sign up for free
or
sign in
.
Other news to note for Feb. 24, 2021
Feb. 24, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alcresta, Addex, Allarity, Beijing Tide, Cybrexa, Cyprium, Daiichi Sankyo, Decibel, Enamine, Generex, Graviton, Inovio, Insilico, Merck, Mydecin, Neonmind, Onconova, Pan-Biome, Poxel, Qiagen, Recce, Regeneron, Roivant, Sentinyl.
BioWorld
Briefs
Other news to note
Coronavirus